Yasui-Furukori N - Search Results

1

Serial case report of high seizure threshold patients that responded to the lengthening of pulse width in ECT.

Katagai H, Yasui-Furukori N, Kawashima H, Suwa T, Tsushima C, Sato Y, Shimoda K, Tasaki H. Katagai H, et al. Neuropsychopharmacol Rep. 2022 Mar;42(1):105-108. doi: 10.1002/npr2.12224. Epub 2021 Dec 24. Neuropsychopharmacol Rep. 2022. PMID: 34953064 Free PMC article.

2

Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature.

Katagai H, Yasui-Furukori N, Kikuchi A, Kaneko S. Katagai H, et al. Psychiatry Clin Neurosci. 2007 Oct;61(5):568-70. doi: 10.1111/j.1440-1819.2007.01709.x. Psychiatry Clin Neurosci. 2007. PMID: 17875038 Free article.

3

Bemegride lengthens seizure duration during electric convulsive therapy in a schizophrenic patient with increased seizure threshold.

Katagai H, Yasui-Furukori N, Kikuchi A, Kaneko S. Katagai H, et al. J ECT. 2009 Mar;25(1):61-3. doi: 10.1097/0b013e3181723725. J ECT. 2009. PMID: 18955899

4

Identification of predictors of post-ictal delirium after electroconvulsive therapy.

Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. Kikuchi A, et al. Psychiatry Clin Neurosci. 2009 Apr;63(2):180-5. doi: 10.1111/j.1440-1819.2009.01930.x. Psychiatry Clin Neurosci. 2009. PMID: 19335388 Free article.

5

Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Suzuki Y, Someya T. Sugawara N, et al. PLoS One. 2014 Jan 23;9(1):e86826. doi: 10.1371/journal.pone.0086826. eCollection 2014. PLoS One. 2014. PMID: 24466260 Free PMC article.

6

The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study.

Yasui-Furukori N, Kikuchi A, Katagai H, Kaneko S. Yasui-Furukori N, et al. Neuropsychiatr Dis Treat. 2014 Jul 3;10:1209-12. doi: 10.2147/NDT.S62490. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25061306 Free PMC article.

7

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K. Aoki A, et al. Neuropsychiatr Dis Treat. 2014 Sep 18;10:1793-8. doi: 10.2147/NDT.S68670. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25258536 Free PMC article.

8

Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients.

Hayashi Y, Watanabe T, Aoki A, Ishiguro S, Ueda M, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K. Hayashi Y, et al. Pharmacopsychiatry. 2015 Nov;48(7):279-85. doi: 10.1055/s-0035-1565069. Epub 2015 Nov 23. Pharmacopsychiatry. 2015. PMID: 26595747

9

High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey.

Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T. Sugai T, et al. BMJ Open. 2015 Dec 9;5(12):e008720. doi: 10.1136/bmjopen-2015-008720. BMJ Open. 2015. PMID: 26656016 Free PMC article.

10

Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey.

Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T. Sugai T, et al. Schizophr Res. 2016 Mar;171(1-3):68-73. doi: 10.1016/j.schres.2016.01.016. Epub 2016 Jan 22. Schizophr Res. 2016. PMID: 26811231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters